For Responsible Negotiation Meetings: Concocting a Vaccine Against Meetingitis

5 Pages Posted: 29 Aug 2015

See all articles by Alain Lempereur

Alain Lempereur

Brandeis University; PON at Harvard Law School

Date Written: August 27, 2015

Abstract

A workday is often summarized as a succession of meetings, much too numerous and often unproductive! This frustration that can affect many negotiations is nicknamed “meetingitis.” This text concocts a vaccine against this disease of our time. A three-step approach aims at more responsible use of meeting times from the introduction to the conclusion, via the main body of the meeting. The prologue or introduction of the meeting focuses on people and process, building connection with the participants and structuring the meeting itself. The dialogue, the central part of the meeting, is devoted to problem solving: identification of issues to address, invention of solutions, evaluation of them before making a decision. The epilogue or conclusion addresses the process of next steps for proper implementation and finishes by a reconnection to the people. In brief, the meeting script is “people and process first, problems next, and finally process and people.”

Keywords: Meetingitis, Meeting Management, Negotiation, People First, People Care, Process Facilitation, Process Moves, Products, Problem Solving, Implementation Phase

JEL Classification: D73, D74, J20, J24, J52, M12

Suggested Citation

Lempereur, Alain Pekar, For Responsible Negotiation Meetings: Concocting a Vaccine Against Meetingitis (August 27, 2015). Harvard PON Working Paper Forthcoming, Available at SSRN: https://ssrn.com/abstract=2652301 or http://dx.doi.org/10.2139/ssrn.2652301

Alain Pekar Lempereur (Contact Author)

Brandeis University ( email )

P.O. Box 549110/MS 035
415 South Street
Waltham, MA 02454
United States
7817363959 (Phone)

HOME PAGE: http://www.brandeis.edu/facguide/person.html?emplid=2ad222e6e8f285436139430fb7cad8fc69bb9a44

PON at Harvard Law School

Cambridge, MA 02138
United States

Do you have negative results from your research you’d like to share?

Paper statistics

Downloads
389
Abstract Views
1,416
Rank
139,529
PlumX Metrics